Nicole N Fahmy is a pharmacist who is specialized in Oncology in Pasadena, California. Patients can reach her at 300 N El Molino Ave Unit 326, Pasadena or contact her on 832-655-8920. Active license number of Nicole N Fahmy is 85397 for Oncology in California. Nicole N Fahmy is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Nicole N Fahmy speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Nicole N Fahmy
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
300 N El Molino Ave Unit 326, Pasadena, California, 91101-1679
Phone:
832-655-8920
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Nicole N Fahmy are as mentioned below.
NPI Number:
1003511015
NPI Enumeration Date:
31 Mar, 2023
NPI Last Update On:
31 Mar, 2023
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Nicole N Fahmy are as mentioned below.
Specialization
License Number
State
Status
Oncology
85397
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
300 N El Molino Ave Unit 326, Pasadena, California
Zip:
91101-1679
Phone Number:
832-655-8920
Fax Number:
--
Patients can reach Nicole N Fahmy at 300 N El Molino Ave Unit 326, Pasadena, California or can call on phone at 832-655-8920.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.